Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Supernus Pharmaceuticals Inc (SUPN)  
$30.07 0.76 (2.59%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 58,625,000
Market Cap: 1.76(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $22.72 - $37.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 98,505 119,208 124,343 450,780
Total Sell Value $3,345,846 $3,929,526 $4,091,741 $15,155,681
Total People Sold 1 5 5 6
Total Sell Transactions 6 10 11 37
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 345
  Page 2 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hudson Frederick M. Director   –       •      –    2024-02-23 4 A $0.00 $0 D/D 3,886 37,117     -
   Barlow Carrolee Director   –       •      –    2024-02-23 4 A $0.00 $0 D/D 3,886 17,201     -
   Newhall Charles W III Director   –       •      –    2024-02-23 4 A $0.00 $0 D/D 3,886 120,975     -
   Gemayel Georges Director   –       •      –    2024-02-23 4 A $0.00 $0 D/D 3,886 17,201     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-23 4 D $29.06 $18,540 D/D (638) 8,570     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-23 4 A $0.00 $0 D/D 1,250 9,208     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-22 4 D $27.94 $10,394 D/D (372) 7,958     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-22 4 A $0.00 $0 D/D 750 8,330     -
   Dec Timothy C Senior Vice-President & CFO   •       –      –    2024-02-22 4 A $0.00 $0 D/D 500 6,004     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-22 4 D $27.94 $9,360 D/D (335) 6,311     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-22 4 A $0.00 $0 D/D 750 6,646     -
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-02-22 4 D $27.94 $6,873 D/D (246) 86,168     -
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-02-22 4 A $0.00 $0 D/D 750 86,414     -
   Rubin Jonathan SVP, Chief Medical Officer   •       –      –    2024-02-22 4 D $27.94 $8,466 D/D (303) 3,958     -
   Rubin Jonathan SVP, Chief Medical Officer   •       –      –    2024-02-22 4 A $0.00 $0 D/D 750 4,261     -
   Khattar Jack A. President, CEO   •       •      –    2024-02-12 4 D $0.00 $0 I/I (16,500) 1,022,450     -
   Khattar Jack A. President, CEO   •       •      –    2024-02-12 4 A $0.00 $0 D/D 16,500 897,005     -
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-01-10 4 AS $27.91 $223,280 D/D (8,000) 85,664 7%     
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-01-10 4 OE $9.24 $73,920 D/D 8,000 93,664     -
   Khattar Jack A. President, CEO   •       •      –    2023-12-22 4 D $27.66 $330,758 D/D (11,958) 880,505     -
   Khattar Jack A. President, CEO   •       •      –    2023-12-22 4 OE $0.00 $0 D/D 25,000 892,463     -
   Rubin Jonathan Sr. VP, Chief Medical Officer   •       –      –    2023-12-22 4 D $27.66 $5,643 D/D (204) 3,243     -
   Rubin Jonathan Sr. VP, Chief Medical Officer   •       –      –    2023-12-22 4 OE $0.00 $0 D/D 600 3,447     -
   Newhall Charles W III Director   –       •      –    2023-11-16 4 S $28.01 $70,025 D/D (2,500) 117,089 -22%     
   Newhall Charles W III Director   –       •      –    2023-11-16 4 OE $9.24 $68,903 D/D 7,457 119,589     -
  345 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us